SpectraCure AB (SPEC)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:SpectraCure AB (SPEC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013200
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SpectraCure AB (SpectraCure) is a healthcare technology company that develops different methods for treatment planning and laser light dose management for cancer treatment. The company develops and therapy system (PDT) commercializes photodynamic with IDOSE for tumors. Its IDOSE platform allows tomographic mapping and controls the interstitial PDT treatment which is used for accurate dosimetry of internal tumors and to avoid damage to healthy tissue. SpectraCure’s IDOSE can also perform real-time adjustments to the dose plan covering the different parts of the target tissue. The company sponsors multicentre phase l/ll clinical trial for recurrent prostate cancer. SpectraCure is headquartered in Lund, Sweden.

SpectraCure AB (SPEC) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
SpectraCure AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
SpectraCure AB, Medical Devices Deals, 2011 to YTD 2017 9
SpectraCure AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
SpectraCure AB, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
SpectraCure Partners with Princess Margaret Hospital 11
SpectraCure Enters into Agreement with Larix 12
Equity Offering 13
SpectraCure Raises USD2.73 Million in IPO of Shares and Warrants 13
SpectraCure AB – Key Competitors 14
SpectraCure AB – Key Employees 15
SpectraCure AB – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
SpectraCure AB, Pharmaceuticals & Healthcare, Key Facts, 2015 2
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
SpectraCure AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
SpectraCure AB, Deals By Therapy Area, 2011 to YTD 2017 8
SpectraCure AB, Medical Devices Deals, 2011 to YTD 2017 9
SpectraCure AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
SpectraCure Partners with Princess Margaret Hospital 11
SpectraCure Enters into Agreement with Larix 12
SpectraCure Raises USD2.73 Million in IPO of Shares and Warrants 13
SpectraCure AB, Key Competitors 14
SpectraCure AB, Key Employees 15

★海外企業調査レポート[SpectraCure AB (SPEC)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • JCR Pharmaceuticals Co Ltd (4552):製薬・医療:M&Aディール及び事業提携情報
    Summary JCR Pharmaceuticals Co Ltd (JCR) manufactures, sells, buys, imports and exports pharmaceutical products. It provides biopharmaceuticals in the field of regenerative medicine for the treatment of rare diseases. The company offers pharmaceuticals to treat growth hormone deficiency, turner synd …
  • Bonavista Energy Corp (BNP):企業の財務・戦略的SWOT分析
    Bonavista Energy Corp (BNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Quidel Corp (QDEL)-医療機器分野:企業M&A・提携分析
    Summary Quidel Corp (Quidel) develops, manufactures and markets rapid diagnostic testing solutions for the detection and diagnosis of critical diseases and other medical conditions. Its major products include immunoassays; molecular assays; virology products including traditional cell lines, specime …
  • Conversant Intellectual Property Management Inc.:企業のM&A・事業提携・投資動向
    Conversant Intellectual Property Management Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Conversant Intellectual Property Management Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descri …
  • ChanTest Corp-製薬・医療分野:企業M&A・提携分析
    Summary ChanTest Corp (ChanTest), a subsidiary of Charles River Laboratories International Inc is a contract research organization that discovers and develops drugs in ion channel and GPCR biology fields. The organization's ion channel products include cell lines and antibodies. Its other products c …
  • Otis Elevator Co:企業の戦略・SWOT・財務情報
    Otis Elevator Co - Strategy, SWOT and Corporate Finance Report Summary Otis Elevator Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • G-III Apparel Group, Ltd.:企業の戦略・SWOT・財務分析
    G-III Apparel Group, Ltd. - Strategy, SWOT and Corporate Finance Report Summary G-III Apparel Group, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Isagen SA ESP:企業の戦略的SWOT分析
    Isagen SA ESP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Sanquin Blood Supply Foundation:企業の戦略的SWOT分析
    Sanquin Blood Supply Foundation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Public Power Corporation SA (PPC)-エネルギー分野:企業M&A・提携分析
    Summary Public Power Corporation S.A. (PPC) is power producer and electricity supply company. The company designs, constructs, maintains and operates power plants. It also generates, transmits and distributes electricity. The company generates power from lignite, fuel oil, and natural gas based plan …
  • MilliporeSigma:企業の戦略的SWOT分析
    MilliporeSigma - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Cosucra Groupe Warcoing SA:戦略・SWOT・企業財務分析
    Cosucra Groupe Warcoing SA - Strategy, SWOT and Corporate Finance Report Summary Cosucra Groupe Warcoing SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Barclaycard:企業の戦略・SWOT・財務情報
    Barclaycard - Strategy, SWOT and Corporate Finance Report Summary Barclaycard - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Cubic Corp (CUB):企業の財務・戦略的SWOT分析
    Cubic Corp (CUB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Pyng Medical Corp:医療機器:M&Aディール及び事業提携情報
    Summary Pyng Medical Corp (Pyng Medical), a subsidiary of Teleflex Medical Canada Inc, is a medical device company that manufactures and markets trauma and resuscitation products. The company offers products such as fast1 intraosseous infusion system, fastresponder sternal intraosseous device, mat t …
  • Brady Corporation:企業の戦略・SWOT・財務分析
    Brady Corporation - Strategy, SWOT and Corporate Finance Report Summary Brady Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Liquor Control Board of Ontario:企業の戦略的SWOT分析
    Liquor Control Board of Ontario - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Ana Holdings Inc:企業のM&A・事業提携・投資動向
    Ana Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ana Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Irving Oil Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Irving Oil Ltd (Irving Oil) is an oil refining and marketing company that processes, transports, refines and distributes oil and natural gas. The company supplies heavy duty diesel and gasoline engine oils, hydraulic fluids and greases, diesel, heating oil, jet fuel, asphalt products and bun …
  • USG Corporation:企業の戦略・SWOT・財務情報
    USG Corporation - Strategy, SWOT and Corporate Finance Report Summary USG Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆